• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications on disease pathogenesis and

Giuseppe

Emeritus
[Source: Journal of Infectious Diseases, full text: (LINK). Abstract, edited.]

Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications on disease pathogenesis and clinical manifestation


Jasper Fuk-Woo Chan 1,*, Kwok-Hung Chan 1,*, Garnet Kwan-Yue Choi 1, Kelvin Kai-Wang To 1,2,3,4, Herman Tse 1,2,3,4, Jian-Piao Cai 1, Man Lung Yeung 1, Vincent Chi-Chung Cheng 1, Honglin Chen 1, Xiao-Yan Che 5, Susanna Kar-Pui Lau 1,2,3,4, Patrick Chiu-Yat Woo 1,2,3,4 and Kwok-Yung Yuen 1,2,3,4,#

Author Affiliations: <SUP>1</SUP>Department of Microbiology <SUP>2</SUP>State Key Laboratory of Emerging Infectious Diseases <SUP>3</SUP>Research Centre of Infection and Immunology <SUP>4</SUP>Carol Yu Centre for Infection, the University of Hong Kong, Queen Mary Hospital, Hong Kong Special Administrative Region, China <SUP>5</SUP>Center for Clinical Laboratory, Zhujiang Hospital, Southern Medical University, Guangzhou, China

#Corresponding author. Mailing address: Carol Yu Centre for Infection, Department of Microbiology, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong Special Administrative Region, China. Phone: (852) 22554892. Fax: (852) 28551241. E-mail: kyyuen@hkucc.hku.hk

* The authors contributed equally to the manuscript


Abstract

The emerging novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) was recently isolated from patients with severe pneumonia and renal failure associated with an unexplained high crude fatality rate of 56%. We performed a cell line susceptibility study with 27 cell lines. HCoV-EMC can infect human respiratory (polarized airway epithelium, Calu-3; embryonic fibroblasts, HFL; lung adenocarcinoma, A549), kidney (embryonic kidney, HEK), intestinal (colorectal adenocarcinoma, Caco-2), liver (hepatocellular carcinoma, Huh-7) cells and histiocytes (malignant histiocytoma, His-1) as evident by a high or increasing viral load in culture supernatants, immunostaining for viral nucleoprotein expression and/or cytopathic effect (CPE). Though infected human neuronal cells (NT2) and monocytes (THP-1, U937) had increase in viral load, their relatively lower viral production corroborated with absent nucleoprotein expression and CPE. This range of human tissue tropism is broader than all other human coronaviruses including SARS-CoV, HCoV-OC43, HCoV-HKU1, HCoV-229E and HCoV-NL63 which may explain the high mortality of this disease. A recent cell line susceptibility study showed that HCoV-EMC can infect primate, porcine and bat cells and therefore may jump interspecies barriers. We found that HCoV-EMC can also infect civet lung fibroblast and rabbit kidney cell lines. These findings have important implications on the diagnosis, pathogenesis and transmission of HCoV-EMC.


Footnotes

Received December 23, 2012. Revision received January 8, 2013. Accepted January 10, 2013.

? The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com
-
-------
 
Back
Top Bottom